Acute Leukemia News

  • FDA Approved Record Number of Drugs in 2018 The FDA approved 59 novel drugs last year, including 19 first-in-class agents, 34 novel drugs for rare diseases, and a record seven biosimilars.
  • Alert FDA Approves First-Ever Drug for Rare Cancer For the first time, the FDA has approved a drug for use specifically for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN), a rare disease with skin and leukemic involvement.

Acute Leukemia Perspective


Acute Leukemia Journal Articles